Stephen V Mahler
@svmahler.bsky.social
Behavioral Neuroscientist, Prof, ICAN co-Director, Ivan Pavlov fan.
Interested in rats, drugs, motivation circuits, orexin, VP, DREADDs, psychedelics, neurodevelopment, etc
https://faculty.sites.uci.edu/mahlerlab/
http://www.youtube.com/@stephenvmahler56
Interested in rats, drugs, motivation circuits, orexin, VP, DREADDs, psychedelics, neurodevelopment, etc
https://faculty.sites.uci.edu/mahlerlab/
http://www.youtube.com/@stephenvmahler56
Reposted by Stephen V Mahler
the senate appropriations bill explicitly limits MYF while the congressional budget doesn't. Making sure the language in the senate appropriations bill ends up in the final budget seems like an clear goal tp push our representatives on
November 5, 2025 at 9:29 PM
the senate appropriations bill explicitly limits MYF while the congressional budget doesn't. Making sure the language in the senate appropriations bill ends up in the final budget seems like an clear goal tp push our representatives on
Damn that’s great!!
October 31, 2025 at 11:14 PM
Damn that’s great!!
Reposted by Stephen V Mahler
5/7 That $200 DOES NOT cover the dozens of hours that reviewers, mainly external scientists, spend on evaluations BEFORE the meetings. This is one of the greatest bargains for American taxpayers, as pharmaceutical companies can pay each consultant THOUSANDS of dollars for their expertise.
October 30, 2025 at 11:02 PM
5/7 That $200 DOES NOT cover the dozens of hours that reviewers, mainly external scientists, spend on evaluations BEFORE the meetings. This is one of the greatest bargains for American taxpayers, as pharmaceutical companies can pay each consultant THOUSANDS of dollars for their expertise.